Savaria declares monthly dividend of $0.0467 per common share

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • Savaria declared a monthly dividend of $0.0467 per common share
  • Payment is scheduled for September 9, 2026
  • Shareholders must be on record by August 31, 2026
  • The payout is designated as an eligible dividend under tax law
powered bylight_fuzz_icon
48863624

*this image is generated using AI for illustrative purposes only.

Savaria Corporation (TSX: SIS) declared a monthly dividend of $0.0467 per common share, continuing its regular payout policy for shareholders.

The dividend is classified as an eligible dividend within the meaning of the Income Tax Act. Payments will be made on September 9, 2026, to shareholders who held shares at the close of business on August 31, 2026.

Dividend Details

Parameter Detail
Dividend Amount $0.0467 per share
Record Date August 31, 2026
Payment Date September 9, 2026
Tax Status Eligible dividend

Savaria operates as a global leader in the accessibility industry, providing solutions such as elevators, stairlifts, and patient handling equipment. The company maintains a global footprint with plants in Canada, the United States, Mexico, Europe, and China.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How might Savaria's consistent dividend policy influence its stock valuation relative to competitors in the medical equipment sector?

What impact could fluctuating global supply chain costs for steel and electronics have on Savaria's ability to maintain this dividend payout ratio?

How will aging demographics in North America and Europe drive future demand for Savaria's accessibility solutions over the next five years?

like15
dislike

Savaria reports record Q2 adjusted EBITDA of $51.8M on 8.4% revenue growth

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights

Savaria Corporation delivered strong Q2 2026 results with $245.8M in revenue and record adjusted EBITDA of $51.8M, driven by organic growth and margin expansion following the completion of the Savaria One initiative. The company also acquired Vipal S.p.A. to expand its European footprint.

powered bylight_fuzz_icon
47513658

*this image is generated using AI for illustrative purposes only.

Savaria Corporation (TSX: SIS) delivered robust second-quarter 2026 results, reporting revenue of $245.8 million, an 8.4 percent increase year-over-year, driven by strong organic growth of 6.6 percent and acquisition contributions. The accessibility equipment manufacturer achieved its best-ever quarterly adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) of $51.8 million, reflecting improved operational efficiency and margin expansion across its segments.

The company’s financial performance was bolstered by the completion of its Savaria One strategic initiative, which eliminated $4.6 million in strategic initiative expenses present in the prior-year quarter. This cost optimization contributed significantly to a 34.1 percent surge in operating income to $35.8 million, lifting the operating margin from 11.8 percent in Q2 2025 to 14.6 percent in Q2 2026. Net earnings rose sharply by 54.4 percent to $25.2 million, or $0.34 per share on a diluted basis, compared to $16.3 million or $0.23 per share in the same period last year.

Segment Performance

Both of Savaria’s primary business segments posted double-digit growth in profitability metrics. The Accessibility segment, which accounted for 78 percent of total revenue, generated $192.0 million, up 8.7 percent year-over-year. Its adjusted EBITDA margin expanded to 23.6 percent from 21.9 percent in Q2 2025. The Patient Care segment saw revenue grow by 7.3 percent to $53.7 million, though its adjusted EBITDA margin contracted slightly to 18.4 percent from 20.9 percent, as the division navigated specific cost pressures despite top-line gains.

Metric Q2 2026 Q2 2025 YoY Change
Revenue $245.8M $226.7M +8.4%
Gross Profit Margin 39.6% 39.0% +60 bps
Operating Income $35.8M $26.7M +34.1%
Adjusted EBITDA $51.8M $46.7M +10.7%
Adjusted EPS $0.35 $0.29 +20.7%

Strategic Developments and Outlook

Savaria announced the acquisition of Vipal S.p.A., effective July 1, 2026, marking a strategic expansion into the European home elevator and commercial lift market. Sébastien Bourassa, President and CEO, highlighted that the acquisition provides immediate opportunities for sales growth with code-compliant, innovative products in key European markets. The company maintains comfortable liquidity with available funds of $333.4 million and reduced net debt to $172.8 million, resulting in a net debt-to-adjusted EBITDA ratio of 0.87, down from 1.03 at year-end 2025.

Looking ahead, Savaria has set a target of approximately 12 percent annual top-line growth over the next five years, aiming to reach roughly $1.6 billion in revenue by 2030. Management intends to maintain adjusted EBITDA margins of at least 20 percent, which should drive adjusted EBITDA per share to approximately $4.25 by 2030. This growth strategy relies on organic initiatives, including new product introductions, alongside selective acquisitions to complement commercial efforts.

What the Numbers Show

The divergence between the 8.4 percent revenue growth and the 10.7 percent increase in adjusted EBITDA indicates successful operating leverage. The elimination of one-time strategic initiative expenses in the current quarter versus the prior year artificially inflated the operating income growth rate; however, the underlying gross profit margin expansion of 60 basis points to 39.6 percent suggests genuine operational improvement. Investors should monitor whether the Patient Care segment can stabilize its margins, as its decline contrasts with the broader company trend of margin expansion.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

How will the integration of Vipal S.p.A. impact Savaria's adjusted EBITDA margins in the near term, given the Patient Care segment's recent margin contraction?

What specific operational strategies will Savaria employ to stabilize and reverse the margin decline in its Patient Care segment while maintaining overall company growth targets?

Given the $172.8 million net debt position, how might Savaria balance future acquisition opportunities with its goal of maintaining a net debt-to-adjusted EBITDA ratio below 1.0?

like19
dislike

More News on Savaria Corporation